Invesco Ltd. 13D and 13G filings for Evofem Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-05-20 3:19 pm Sale | 2021-05-18 | 13D | Evofem Biosciences, Inc. EVFM | Invesco Ltd. IVZ | 316 13.000% | -4,324 (-93.19%) | Filing |
| 2021-04-27 3:31 pm Sale | 2021-04-22 | 13D | Evofem Biosciences, Inc. EVFM | Invesco Ltd. IVZ | 4,639 8.400% | -614 (-11.68%) | Filing |
| 2021-03-30 6:53 pm Sale | 2021-03-25 | 13D | Evofem Biosciences, Inc. EVFM | Invesco Ltd. IVZ | 5,253 9.900% | -1,801 (-25.53%) | Filing |
| 2020-06-09 06:58 am Purchase | 2020-06-05 | 13D | Evofem Biosciences, Inc. EVFM | Invesco Ltd. IVZ | 7,054 16.800% | 754 (+11.97%) | Filing |